Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Gulf Resources
GURE
$9.31M
| $291K | ﹤0.01% |
176,489
-13,803
| -7% | -$22.8K |
|
|
SCTL
3002
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $291K | ﹤0.01% |
831,217
-4,800
| -0.6% | -$1.68K |
|
3003
Mannatech
MTEX
$14.8M
| $290K | ﹤0.01% |
35,799
-1,600
| -4% | -$13K |
|
3004
NuScale Power
SMR
$4.8B
| $290K | ﹤0.01% |
+88,200
| New | +$290K |
|
3005
Coffee Holding Co
JVA
$23.5M
| $288K | ﹤0.01% |
315,964
-6,000
| -2% | -$5.47K |
|
3006
Dimensional US Targeted Value ETF
DFAT
$11.8B
| $288K | ﹤0.01% |
5,500
-9,900
| -64% | -$518K |
|
3007
electroCore
ECOR
$36.6M
| $288K | ﹤0.01% |
48,416
+5,800
| +14% | +$34.5K |
|
3008
SWK Holdings
SWKH
$176M
| $287K | ﹤0.01% |
20,697
+1,893
| +10% | +$26.3K |
|
3009
Educational Development Corp
EDUC
$9.53M
| $285K | ﹤0.01% |
245,545
+2,800
| +1% | +$3.25K |
|
3010
Replimune Group
REPL
$446M
| $285K | ﹤0.01% |
33,853
-52,847
| -61% | -$445K |
|
3011
ARS Pharmaceuticals
SPRY
$987M
| $285K | ﹤0.01% |
52,000
-85,700
| -62% | -$470K |
|
3012
Western Union
WU
$2.72B
| $285K | ﹤0.01% |
+23,921
| New | +$285K |
|
3013
Broadwind
BWEN
$51.2M
| $282K | ﹤0.01% |
101,700
-5,928
| -6% | -$16.4K |
|
3014
Acushnet Holdings
GOLF
$4.4B
| $278K | ﹤0.01% |
4,400
-67,000
| -94% | -$4.23M |
|
|
WIMI
3015
WiMi Hologram Cloud
WIMI
$42M
| $278K | ﹤0.01% |
34,360
-160
| -0.5% | -$1.3K |
|
3016
Compass Therapeutics
CMPX
$609M
| $276K | ﹤0.01% |
176,799
+149,999
| +560% | +$234K |
|
3017
Retractable Technologies
RVP
$24.4M
| $276K | ﹤0.01% |
248,574
+40,310
| +19% | +$44.8K |
|
|
NRGD
3018
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
| $276K | ﹤0.01% |
1,200
-500
| -29% | -$115K |
|
|
NFGC
3019
New Found Gold
NFGC
$501M
| $275K | ﹤0.01% |
+78,700
| New | +$275K |
|
3020
Dave Inc
DAVE
$3.08B
| $274K | ﹤0.01% |
+32,700
| New | +$274K |
|
|
SDPI
3021
DELISTED
Superior Drilling Products Inc.
SDPI
| $273K | ﹤0.01% |
381,810
-133,431
| -26% | -$95.4K |
|
|
TEAD
3022
Teads Holding Co. Common Stock
TEAD
$158M
| $272K | ﹤0.01% |
62,000
-18,300
| -23% | -$80.3K |
|
|
AKTS
3023
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $272K | ﹤0.01% |
325,900
-280,758
| -46% | -$234K |
|
3024
Biglari Holdings Class A
BH.A
$951M
| $270K | ﹤0.01% |
340
+10
| +3% | +$7.94K |
|
3025
Humacyte
HUMA
$236M
| $270K | ﹤0.01% |
95,100
-12,400
| -12% | -$35.2K |
|